Sodium Valproate Inhibits the Growth of Human Cholangiocarcinoma In Vitro and In Vivo

Background. None of treatment options for Cholangiocarcinoma (CCA), including surgery, adjuvant radiotherapy and chemotherapy, and ultimately liver transplantation, have been shown to substantially improve the survival rate in patients with CCA. Valproic acid (VPA), a histone deacetylase inhibitor,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wang, Bing, Yang, Rui, Wu, Yue, Li, Hongbo, Hu, Zouxiao, Chen, Yongjun, Zou, Shengquan
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845332/
https://ncbi.nlm.nih.gov/pubmed/24324485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/374593
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky